摘要
Immunotherapy has revolutionized cancer treatment by leveraging the intrinsic immune system.Although tremendous attention has focused on developing a new class of drugs enhancing or normalizing anti-tumor immunity,little effort was devoted to considering their time-of-day difference of administration in therapeutic efficacy.
